Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/9676
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Instituto Nacional de Câncer (Brasil) | - |
dc.contributor.author | Instituto Nacional de Câncer José Alencar Gomes da Silva | - |
dc.contributor.author | INCA | - |
dc.date.accessioned | 2022-07-29T17:55:10Z | - |
dc.date.available | 2022-07-29T17:55:10Z | - |
dc.date.issued | 2011-11 | - |
dc.identifier.uri | http://sr-vmlxaph03:8080/jspui/handle/123456789/9676 | - |
dc.subject | Antineoplásicos | pt_BR |
dc.subject | Antineoplastic Agents | pt_BR |
dc.subject | Política de Inovação e Desenvolvimento | pt_BR |
dc.subject | Innovation and Development Policy | pt_BR |
dc.subject | Política de Innovación y Desarrollo | pt_BR |
dc.title | MS cria Rede Nacional de Desenvolvimento e Inovação de Fármacos Anticâncer | pt_BR |
dc.title.alternative | Informe INCA 294 | pt_BR |
dc.Type | Article | pt_BR |
Appears in Collections: | Informe INCA 294 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Informe INCA 294-11.pdf | 48.43 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.